Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report

Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report

Background: RECOVER is a randomized sham-controlled trial of vagus nerve stimulation and the largest such trial conducted with a psychiatric neuromodulation intervention. Objective: To describe pre-implantation baseline clinical characteristics and treatment history of patients with unipolar, major...

Full description

Bibliographic Details
Main Authors: Charles R. Conway, Scott T. Aaronson, Harold A. Sackeim, Walter Duffy, Mary Stedman, João Quevedo, Rebecca M. Allen, Patricio Riva-Posse, Matthew A. Berger, Gustavo Alva, Mohd Azfar Malik, David L. Dunner, Ivan Cichowicz, Heather Luing, John Zajecka, Ziad Nahas, Brian J. Mickey, Anita S. Kablinger, Christopher L. Kriedt, Mark T. Bunker, Ying-Chieh (Lisa) Lee, Olivia Shy, Shannon Majewski, Bryan Olin, Quyen Tran, A. John Rush
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Brain Stimulation
Subjects:
Electroconvulsive therapy
Esketamine
RECOVER trial
Transcranial magnetic stimulation (TMS)
Treatment-resistant depression (TRD)
Vagus nerve stimulation (VNS)
Online Access:http://www.sciencedirect.com/science/article/pii/S1935861X24000524

Internet

http://www.sciencedirect.com/science/article/pii/S1935861X24000524

Similar Items